The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Open accessAbstract
Cytosolic NOD-like receptors (NLRs) have been associated with human diseases including infections, cancer, and autoimmune and inflammatory disorders. These innate immune pattern recognition molecules are essential for controlling inflammatory mechanisms through induction of cytokines, chemokines, and anti-microbial genes. Upon activation, some NLRs form multi-protein complexes called inflammasomes, while others orchestrate caspase-independent nuclear factor kappa B (NF-κB) and mitogen activated protein kinase (MAPK) signaling. Moreover, NLRs and their downstream signaling components engage in an intricate crosstalk with cell death and autophagy pathways, both critical processes for cancer development. Recently, increasing evidence has extended the concept that chronic inflammation caused by abberant NLR signaling is a powerful driver of carcinogenesis, where it abets genetic mutations, tumor growth, and progression. In this review, we explore the rapidly expanding area of research regarding the expression and functions of NLRs in different types of cancers. Furthermore, we particularly focus on how maintaining tissue homeostasis and regulating tissue repair may provide a logical platform for understanding the liaisons between the NLR-driven inflammatory responses and cancer. Finally, we outline novel therapeutic approaches that target NLR signaling and speculate how these could be developed as potential pharmaceutical alternatives for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–232 of 232
Hawkins, C. J., Uren, A. G., Häcker, G. A., Medcalf, R. L., & Vaux, D. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13786 · Cited by 102
Maruyama, K., Ochiai, A., Akimoto, S., Nakamura, S., Baba, S., Moriya, Y., & Hirohashi, S. (2000) · Oncology · doi:10.1159/000012187 · Cited by 101
RIP2 Is a Raf1-activated Mitogen-activated Protein Kinase Kinase
Navas, T. A., Baldwin, D. T., & Stewart, T. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33684 · Cited by 98
Homer, C. R., Kabi, A., Marina–García, N., Sreekumar, A., Nesvizhskii, A. I., Nickerson, K. P., Chinnaiyan, A. M., Núñez, G., & McDonald, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326835 · Cited by 94
NLRX1 does not inhibit MAVS-dependent antiviral signalling
Soares, F., Tattoli, I., Wortzman, M. E., Arnoult, D., Philpott, D. J., & Girardin, S. E. (2012) · Innate Immunity · doi:10.1177/1753425912467383 · Cited by 92
Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology
Кутихин, А. Г. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.06.003 · Cited by 89
Chrétien, A.-S., Roy, A. L., Vey, N., Prébet, T., Blaise, D., Fauriat, C., & Olive, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00122 · Cited by 89
Faustin, B., Chen, Y., Zhai, D., Negrate, G. L., Lartigue, L., Satterthwait, A. C., & Reed, J. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809414106 · Cited by 86
Busca, A., Saxena, M., & Kumar, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312660 · Cited by 84
Self-citationBeneficial and Detrimental Roles of NLRs in Carcinogenesis
Janowski, A. M., Kolb, R. H., Zhang, W., & Sutterwala, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00370 · Cited by 82
Activation of the NLRP3 inflammasome by intracellular poly I:C
Rajan, J. V., Warren, S. E., Miao, E. A., & Aderem, A. A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.036 · Cited by 81
The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy
Lei, Y. L., Wen, H., & Ting, J. P. ‐. (2013) · Autophagy · doi:10.4161/auto.23026 · Cited by 80
Colon Carcinogenesis in Inflammatory Bowel Disease
Itzkowitz, S. H. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200305001-00012 · Cited by 80
Nickerson, K. M., Sisk, T. J., Inohara, N., Yee, C. S. K., Kennell, J. A., Cho, M.-C., Yannie, P. J., Núñez, G., & Chang, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101295200 · Cited by 79
Understanding the non-canonical pathways involved in p53-mediated tumor suppression
Hager, K. M., & Gu, W. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt487 · Cited by 78
NLRX1/NOD5 deficiency does not affect MAVS signalling
Rebsamen, M., Vázquez, J., Tardivel, A., Guarda, G., Curran, J. A., & Tschopp, J. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.64 · Cited by 74
Arthur, J. C., Lich, J. D., Aziz, R. K., Kotb, M., & Ting, J. P. ‐. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6291 · Cited by 70
Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis
Sadasivam, S., Gupta, S., Radha, V., Batta, K., Kundu, T. K., & Swarup, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208201 · Cited by 69
Anti-Apoptotic Genes in the Survival of Monocytic Cells During Infection
Busca, A., Saxena, M., Kryworuchko, M., & Kumar, A. (2009) · Current Genomics · doi:10.2174/138920209788920967 · Cited by 64
Self-citationTokunaga, F., & Iwaï, K. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0148 · Cited by 60
Molecular regulation of inflammation and cell death
Yeretssian, G., Labbè, K., & Saleh, M. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.015 · Cited by 53
Self-citationHu, B., Elinav, E., & Flavell, R. A. (2011) · Cell Cycle · doi:10.4161/cc.10.12.16008 · Cited by 50
Effector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37 · cited 4×
“Following this complex formation, IKKs (IKKα and IKKβ) get phosphorylated eventually driving the phosphorylation and degradation of IκBα and subsequent transcription of NF-κB target genes (5, 89, 92) (Figure 2).”
BackgroundInfluentialSelf-citationRICK Activates a NF-κB-dependent Anti-human Cytomegalovirus Response
Eickhoff, J., Hanke, M., Stein-Gerlach, M., Kiang, T. P., Herzberger, K., Habenberger, P., Müller, S., Klebl, B., Marschall, M., Stamminger, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312893200 · Cited by 35
Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer
Lener, M. R., Oszutowska–Mazurek, D., Castañeda, J., Kurzawski, G., Suchy, J., Nej‐Wołosiak, K., Byrski, T., Huzarski, T., Gronwald, J., Szymańska, A., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9057-z · Cited by 35
Saxena, M., Busca, A., Pandey, S., Kryworuchko, M., & Kumar, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100115 · Cited by 31
Self-citationMouse Mutagenesis Using N-Ethyl-N-Nitrosourea (ENU): Figure 1.Preprint
Salinger, A. P., & Justice, M. J. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot4985 · Cited by 21
Is BID required for NOD signalling?
Nachbur, U., Vince, J. E., O’Reilly, L. A., Strasser, A., & Silke, J. (2012) · Nature · doi:10.1038/nature11366 · Cited by 18
Nod-like receptors in head and neck squamous cell carcinoma
Millrud, C. R., Kvarnhammar, A. M., Tajti, J., Munck‐Wikland, E., Uddman, R., & Cardell, L. (2013) · Acta Oto-Laryngologica · doi:10.3109/00016489.2013.831476 · Cited by 16
Yomade, O., Spies‐Weisshart, B., Glaser, A., Schnetzke, U., Hochhaus, A., & Scholl, S. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1734-0 · Cited by 13
Inhibitory Effect of Liposomal MDP-Lys on Lung Metastasis of Transplantable Osteosarcoma in Hamster
Nitta, Y., Sugita, T., Ikuta, Y., & Murakami, T. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000001108747417 · Cited by 7
Yeretssian, G., Correa, R. G., Doiron, K., Fitzgerald, P., Dillon, C. P., Green, D. R., Reed, J. C., & Saleh, M. (2012) · Nature · doi:10.1038/nature11367 · Cited by 3
Self-citation
Cited by
An Update on the Genus Aeromonas: Taxonomy, Epidemiology, and Pathogenicity
Fernández-Bravo, A., & Figueras, M. J. (2020) · Microorganisms · doi:10.3390/microorganisms8010129 · Cited by 699
Groeger, S., & Meyle, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00208 · Cited by 473
Gut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482
Ulgen, E., Ozisik, O., & Sezerman, O. U. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00858 · Cited by 469
Transcriptional regulation of myeloid-derived suppressor cells
Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri0515-204r · Cited by 372
Metadata
- Authors
- Saxena, M., & Yeretssian, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014-07-14
- Volume
- 5
- Pages
- 327-327
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2009755744
- Cited by
- 274
- References
- 232
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.